S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Urgent alert: open this for a huge profit potential (Ad)
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
How Biden has already won 2024 (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
He Is Giving Away Bitcoin (Ad)
Can Netflix Stock Continue Into All-Time Highs After Earnings?
Shares of Walmart-backed Ibotta soar on public debut
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Urgent alert: open this for a huge profit potential (Ad)
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
How Biden has already won 2024 (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
He Is Giving Away Bitcoin (Ad)
Can Netflix Stock Continue Into All-Time Highs After Earnings?
Shares of Walmart-backed Ibotta soar on public debut
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Urgent alert: open this for a huge profit potential (Ad)
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
How Biden has already won 2024 (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
He Is Giving Away Bitcoin (Ad)
Can Netflix Stock Continue Into All-Time Highs After Earnings?
Shares of Walmart-backed Ibotta soar on public debut
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Urgent alert: open this for a huge profit potential (Ad)
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
How Biden has already won 2024 (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
He Is Giving Away Bitcoin (Ad)
Can Netflix Stock Continue Into All-Time Highs After Earnings?
Shares of Walmart-backed Ibotta soar on public debut
Free Trial
NASDAQ:ROSG

(ROSG) (ROSG) Stock Price, News & Analysis

→ Now Open: Crypto emergency update (From InvestorPlace) (Ad)
Free ROSG Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$0.42
▼
$0.44
50-Day Range
$0.43
▼
$0.43
52-Week Range
$0.23
▼
$2.75
Volume
169,599 shs
Average Volume
81,512 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
ROSG stock logo

About (ROSG) Stock (NASDAQ:ROSG)

Rosetta Genomics Ltd. provides therapeutic, diagnostic product development and medical research services. The company develops and commercializes new diagnostic tests based on various genomics markers, including DNA, microRNA and protein biomarkers and using various technologies, including, qPCR, microarrays, next generation sequencing and fluorescence in situ hybridization. It offers proprietary microRNA technologies, such as Rosetta Cancer Origin, mi-KIDNEY, and RosettaGX Reveal Test. The company was founded by Isaac Bentwich on March 9, 2000 and is headquartered in Rehovot, Israel.

ROSG Stock News Headlines

February 27, 2024 | morningstar.com
Rosetta Genomics Ltd ROSGQ
October 7, 2023 | bizjournals.com
Life science company founder: Lowering cost of DNA sequencing leads to groundbreaking advancements in personalized medicine
April 19, 2024 | InvestorPlace (Ad)
Now Open: Crypto emergency update
During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.
September 15, 2023 | msn.com
What Do You Say on Rosh Hashanah? Blessings, Prayers, Greetings for Holiday
September 15, 2023 | msn.com
Rosh Hashanah 2023: What to know about Judaism's holiest day
April 27, 2023 | finance.yahoo.com
AI (Artificial Intelligence) in Genomics Market Research Report 2023
April 25, 2023 | marketwatch.com
Laboratory Developed Test Market Growth and Forecast Till 2031
April 21, 2023 | benzinga.com
The Global Genetic Analysis Market size is expected to reach $22.31 billion by 2028 | Brandessence Market Research
April 19, 2024 | InvestorPlace (Ad)
Now Open: Crypto emergency update
During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.
March 29, 2023 | marketwatch.com
Laboratory Developed Test Market Major Players, Anlysis and Forecast till 2031
March 26, 2023 | marketwatch.com
Laboratory-developed Testing Market Size and Forecast till 2030
February 23, 2023 | finance.yahoo.com
Global Consumer Genomics Market (2022 to 2027) - Featuring 23andMe, Ancestry, Color Health and Helix OpCo Among Others
February 20, 2023 | marketwatch.com
MicroRNA Market to Grow Significantly by Leading Players 2023 to 2028
February 19, 2023 | marketwatch.com
Global MicroRNA Market Report Historical, Current, and Projected Size, in terms of value 2030 By VMReports
February 17, 2023 | marketwatch.com
Prostate Cancer Screening Market Size Related To Time And Cost Is Expected To Grow The Industry In Upcoming Years To 2027
February 17, 2023 | marketwatch.com
Prostate Cancer Screening Market Outlook 2023 and Forecast to 2028 with Top Countries Data
February 15, 2023 | marketwatch.com
Laboratory Developed Test Market Massive Growth Strikes Due To Technological Innovation During 2023-2028
January 31, 2023 | marketwatch.com
Prostate Cancer Screening Market Growth, Opportunity, Trends, Service, Forecast To 2028
January 19, 2023 | finance.yahoo.com
Global Plant Genomics Market to Reach $14 Billion by 2027
January 14, 2023 | thestreet.com
Rosetta Genomics (ROSG) Stock Closed Up on Cantor Fitzgerald Rating
January 11, 2023 | marketwatch.com
Laboratory Developed Test Market : Projections and Regional Outlook, Depth Study, Analysis, Key Drivers, Top Players, Trends and Forecast 2023-2029
January 5, 2023 | finance.yahoo.com
Spatial Genomics and Transcriptomics Market worth $800 million by 2027 - Exclusive Report by MarketsandMarkets™
December 9, 2022 | marketwatch.com
Market Research Report: Future Trends in the Kidney Cancer Diagnostics Industry from 2022 to 2028.
December 6, 2022 | marketwatch.com
Prostate Cancer Screening Market 2022 Report Offers Key Futuristic Top Trends And Competitive Landscape By 2028
December 5, 2022 | marketwatch.com
Prostate Cancer Screening Market 2023 Expected to Reach Significant Rate by 2025
December 3, 2022 | msn.com
Martin Dubravka makes transfer admission and explains why he joined Manchester United
November 12, 2022 | finance.yahoo.com
Government of Canada invests over $5.6 million to help early-stage genomics companies bring new products to market
See More Headlines
Receive ROSG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (ROSG) and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/19/2016
Today
4/18/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:ROSG
CUSIP
N/A
CIK
1362959
Web
www.rosettagenomics.com
Phone
972732220700
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
Beginners Guide To Retirement Stocks Cover
Beginners Guide To Retirement Stocks

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

ROSG Stock Analysis - Frequently Asked Questions

How were (ROSG)'s earnings last quarter?

(ROSG) (NASDAQ:ROSG) posted its earnings results on Thursday, May, 19th. The medical research company reported ($0.18) EPS for the quarter, missing the consensus estimate of ($0.16) by $0.02. The medical research company earned $2.60 million during the quarter, compared to analyst estimates of $3.36 million.

What other stocks do shareholders of (ROSG) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other (ROSG) investors own include Agenus (AGEN), Bausch Health Companies (BHC), Endocyte (ECYT), Intercept Pharmaceuticals (ICPT), Amicus Therapeutics (FOLD), BIOLASE (BIOL), EyePoint Pharmaceuticals (EYPT), OPKO Health (OPK), (SCMP) (SCMP) and Sarepta Therapeutics (SRPT).

This page (NASDAQ:ROSG) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Biden’s $374B Giveaway Into This Sector
DTI
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
Paradigm Press
He Is Giving Away Bitcoin
Crypto Swap Profits
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research
Urgent alert: open this for a huge profit potential
Timothy Sykes
The #1 Crypto for 2024
InvestorPlace
How Biden has already won 2024
Porter & Company